4-hydroxy-equilin

Known as: 4-hydroxyequilin 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-2010
0119902010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Estrogen-DNA adducts are potential biomarkers for assessing the risk and development of estrogen-associated cancers. 4… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
2003
2003
Increased incidence of breast, ovarian and endometrial cancers are observed in women receiving estrogen replacement therapy (ERT… (More)
  • figure 1
  • figure 3
  • figure 4
  • figure 6
  • figure 7
Is this relevant?
1999
1999
The risk factors for women developing breast and endometrial cancers are all associated with a lifetime of estrogen exposure… (More)
Is this relevant?
1998
1998
The risk factors for women developing breast and endometrium cancers are all associated with a lifetime of estrogen exposure… (More)
Is this relevant?
1990
1990
4-Hydroxyequilin, 4-hydroxyequilenin, and 16 alpha-hydroxyequilenin were synthesized as authentic specimens for the metabolic… (More)
Is this relevant?